Research Groups and R&D Platforms: Cancer
Research Group:
Mesoporous drug carriers/ Electrostatics / Pharmaceutical Physics
Jarno Salonen
jarno.salonen[at]utu.fi
Industrial Physics Laboratory,
University of Turku
Biopharmaceuticals, Cancer, Chemical Physics, Diabetes, Drug delivery, Drug solubility, Drug stability, Drug target, Electron microscopy, FTIR or RAMAN spectroscopy, Lead optimization, Microstructure analysis, Nanoparticles, NMR, Obesity, Particle size analysis, Pharmacy, Physico-chemical properties, Physics, Polymorph analysis, Porosity, Powder X-ray diffraction, Preclinical development, Surface area, Thermal analysis, Zeta potential
Research Group:
Cancer Cell Signaling
Jukka Westermarck
jukwes[at]utu.fi
Turku Bioscience Centre and Institute of Biomedicine,
University of Turku
Assay development, Basic research, Biochemistry, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Disease models, Drug delivery, Genomics, Lung cancer, Molecular Biology, Molecular Cell Biology, Nanoparticles, Next-generation sequencing, Pathology, Personalized medicine, Prostate cancer, Proteomics, Receptor, Screening, Signaling, Squamous cell carcinoma, Systems Biology, Target discovery, X-ray crystallography
Research Group:
Bioorganic Group
Pasi Virta
pamavi[at]utu.fi
Bioorganic chemistry group, Department of Chemistry,
University of Turku
Atomic-force microscopy, Cancer, Drug target, Hit to lead, Lead optimization, Medicinal chemistry, Nanoparticles, Neurological disorders, NMR, Nucleic acids, Organic Chemistry, Organic compounds, PET, Synthetic chemistry, Thermal analysis
Research Group:
Radiopharmaceuticals for positron emission tomography (PET) imaging
Xiang-Guo Li
xiali[at]utu.fi
Turku PET Centre,
University of Turku
Antibodies, Assay development, Biomedicine, Cancer, Cardiovascular diseases, Clinical Chemistry, Drug delivery, Drug solubility, Drug stability, Formulation, Imaging, In Vivo Diagnostics, Infection, Inflammation, Medicinal chemistry, Metabolic diseases, Molecular diagnostics, Nanoparticles, Nucleic acids, Organic Chemistry, Organic compounds, Personalized medicine, PET, Pharmacy, Physico-chemical properties, Preclinical development, Synthetic chemistry
Research Group:
Tissues Regeneration and Cancer
Fang Cheng
fang.cheng[at]utu.fi
Turku Bioscience Centre,
University of Turku
Assay development, Biomarker, Biomedicine, Biotechnology, Cancer, Colorectal cancer, Disease models, Drug target, High throughput imaging, Imaging, Inflammation, Lead optimization, Metabolic diseases, Molecular Cell Biology, Natural Compounds, Personalized medicine, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Signaling of Receptor Tyrosine Kinases in Cancer and Development
Klaus Elenius
klaele[at]utu.fi
Institute of Biomedicine,
University of Turku
Basic research, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Drug delivery, Drug target, Genomics, Lung cancer, Melanoma, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Pathology, Personalized medicine, Receptor, Signaling, Squamous cell carcinoma, Target discovery
